X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (292) 292
life sciences & biomedicine (285) 285
humans (262) 262
female (187) 187
male (181) 181
diabetes (171) 171
risk factors (158) 158
middle aged (150) 150
endocrinology & metabolism (143) 143
aged (110) 110
abridged index medicus (91) 91
type 2 diabetes (89) 89
adult (72) 72
diabetes mellitus, type 2 - drug therapy (69) 69
cardiovascular diseases (63) 63
glucose (61) 61
cardiovascular disease (57) 57
diabetes mellitus (57) 57
hypoglycemic agents - therapeutic use (57) 57
blood glucose - metabolism (55) 55
cardiovascular system & cardiology (55) 55
research (55) 55
cardiac & cardiovascular systems (51) 51
general & internal medicine (51) 51
medicine, general & internal (51) 51
health aspects (50) 50
diabetes mellitus, type 2 - complications (44) 44
clinical trials (42) 42
insulin (42) 42
diabetes mellitus, type 2 - blood (38) 38
treatment outcome (38) 38
mortality (37) 37
analysis (36) 36
care and treatment (36) 36
follow-up studies (36) 36
cardiovascular diseases - prevention & control (35) 35
medical research (33) 33
complications and side effects (31) 31
blood pressure (30) 30
glycated hemoglobin a - metabolism (30) 30
drug therapy (29) 29
cardiovascular diseases - etiology (28) 28
cardiovascular diseases - epidemiology (27) 27
diabetes mellitus, type 2 - epidemiology (27) 27
dextrose (26) 26
myocardial infarction (26) 26
prognosis (25) 25
body mass index (24) 24
hyperglycemia (24) 24
prospective studies (24) 24
risk assessment (24) 24
blood glucose - drug effects (23) 23
heart attacks (23) 23
incidence (23) 23
prevention (23) 23
usage (23) 23
studies (22) 22
double-blind method (21) 21
glycated hemoglobin a - analysis (21) 21
original research (21) 21
patient outcomes (21) 21
physiological aspects (21) 21
cardiovascular (20) 20
epidemiology (20) 20
peripheral vascular disease (20) 20
diabetes therapy (19) 19
diabetics (19) 19
hypoglycemic agents - administration & dosage (19) 19
randomized controlled trials as topic (19) 19
stroke (19) 19
animals (18) 18
cardiovascular diseases - mortality (18) 18
dosage and administration (18) 18
heart failure (18) 18
insulin glargine (18) 18
internal medicine (18) 18
hypoglycemic agents - adverse effects (17) 17
insulin resistance (17) 17
proportional hazards models (17) 17
blood glucose - analysis (16) 16
diabetic angiopathies - prevention & control (16) 16
glucose tolerance test (16) 16
health risk assessment (16) 16
heart attack (16) 16
hypoglycemia (16) 16
pregnancy (16) 16
research design (16) 16
time factors (16) 16
cholesterol (15) 15
diabetes mellitus - epidemiology (15) 15
diabetes mellitus, type 2 - prevention & control (15) 15
hemoglobin (15) 15
regression analysis (15) 15
risk (15) 15
biomarkers - blood (14) 14
blood sugar (14) 14
cohort studies (14) 14
diabetes mellitus, type 2 - mortality (14) 14
insulin - therapeutic use (14) 14
prevalence (14) 14
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9958, pp. 1936 - 1941
Journal Article
The New England journal of medicine, ISSN 1533-4406, 12/2015, Volume 373, Issue 23, pp. 2247 - 2257
In this randomized study, the addition of lixisenatide, a glucagon-like peptide 1–receptor agonist, to usual care in patients with type 2 diabetes and a recent... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Glycated Hemoglobin A - analysis | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Acute Coronary Syndrome - drug therapy | Myocardial Infarction - complications | Acute Coronary Syndrome - complications | Angina, Unstable - complications | Diabetes Mellitus, Type 2 - mortality | Treatment Failure | Cardiovascular Diseases - epidemiology | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Glucagon-Like Peptide-1 Receptor - agonists | Peptides - adverse effects | Peptides - therapeutic use | Type 2 diabetes | Treatment outcome | Care and treatment | Analysis | Hypoglycemic agents | Dosage and administration | Acute coronary syndrome | Myocardial infarction | Cerebral infarction | Glucagon | Diabetes mellitus | Hypersensitivity | Pancreatitis | Angina | Glucose | Hypoglycemia | Morbidity | Studies | Heart rate | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Pancreas | Drug therapy | Diabetes mellitus (non-insulin dependent) | Heart diseases | Glucagon-like peptide 1 | Clinical trials | Regulatory approval | Hemoglobin | Drug dosages | Heart failure | Mortality | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Lancet neurology, ISSN 1474-4422, 2011, Volume 10, Issue 11, pp. 969 - 977
Journal Article